Yellow Fever Vaccine Industry Projected to Experience Accelerated Growth by 2030

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What is the Market Size Outlook for the Yellow Fever Vaccine Market?
The yellow fever vaccine market size has grown steadily in recent years. It will grow from $4.74 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, public health initiatives.

The yellow fever vaccine market size is expected to see steady growth in the next few years. It will grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to climate-driven mosquito spread, increasing global travel, expansion of vaccination infrastructure, higher funding for disease prevention, stronger outbreak preparedness. Major trends in the forecast period include expansion of routine immunization programs, rising demand from international travelers, increased government-led vaccination campaigns, growing use of single-dose vaccines, focus on endemic disease prevention.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Are the Critical Growth Contributors in the Yellow Fever Vaccine Market?
The increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for tourism, business, or personal purposes. International travel is rising due to growing global mobility supported by economic recovery and easing post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by providing mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, up from 0.96 billion in 2022, an increase of 0.326 billion international tourists year-on-year. Therefore, increasing international travel is driving the growth of the yellow fever vaccine market.

What Are the Main Segments of the Yellow Fever Vaccine Market?
The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid
2) By Application: Routine Immunization, Travelers, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

How Are Current Trends Influencing the Yellow Fever Vaccine Market Growth?
Major companies operating in the yellow fever vaccine market are increasingly focusing on developing innovative solutions, such as T-cell adaptive booster vaccines, to enhance long-term immunity, improve vaccine efficacy, and address limitations of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are vaccines designed to strengthen the immune system by specifically enhancing T-cell responses, which help the body recognize and fight infections more effectively compared to traditional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, launched Yellow Fever Vaccination to provide travelers with protection against the mosquito-borne viral disease and issue the internationally recognized vaccination certificate. The initiative aims to increase accessibility to the vaccine within Telangana, reducing the need for long-distance travel to other authorized centers. Additionally, the program ensures adherence to international health regulations by offering safe administration under medical supervision, particularly for individuals with contraindications.

Who Are the Leading Players in the Yellow Fever Vaccine Market?
Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Get the full yellow fever vaccine market report here:
https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which region represents the fastest-growing market for the Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn